Could amniotic fluid injections regrow hair? new trial begins
NCT ID NCT07482423
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an injection called XVIE, made from processed human amniotic fluid, is safe and might help regrow hair in adults with common pattern baldness. Thirty participants will receive either XVIE or a placebo injected into the scalp, with two treatments 90 days apart. Neither participants nor researchers will know who gets the real treatment. The main goal is safety, but researchers will also check if hair count or density improves over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
processed human amniotic fluid (XVIE)
What this could lead to
If it works, this could point toward a new treatment for common pattern hair loss that stimulates natural hair regrowth without surgery.
What could go wrong
This is an early phase 1/2 trial with only 30 people, so results may not apply widely. The main goal is safety, not proof of effectiveness, and hair regrowth may not occur or may be minimal.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advanced Dermatology and Cosmetic Surgery
Orlando, Florida, 32827, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kindred Hair & Skin Center
Marriottsville, Maryland, 21104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••